Thoratec Decides Against Purchase
August 2, 2009 by Mark Ellis
Filed under Business
Thoratec, a company with an expertise in therapies aimed at advanced heart failure, has reportedly decided against its plan to purchase HeartWare International for $282 million. The decision was made after the United States Federal Trade Commission said that they would challenge the sale.
HeartWare International is based in Australia and is known for developing and manufacturing implantable heart pumps for patients with advanced heart failure. Back in February, when the initial plan was announced, Thoratec was excited about the possibilities of purchasing HeartWare International — both for the company and potential patients around the world.
Said Gary F. Burbach, the CEO …read more
